Cited by 164Diabetes, Cardiovascular Risks, and LipoproteinsNitric Oxide and Endothelin EffectsAdipokines, Inflammation, and Metabolic Diseases

Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Hoorn Study

Open access
de Jager, Jolien, Dekker, Jacqueline M., Kooy, Adriaan, Kostense, Piet J., Nijpels, Giel, Heine, Rob J., Bouter, Lex M., Stehouwer, Coen D.A.·2006·Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Objective— The mechanisms responsible for the increased cardiovascular disease risk that accompanies type 2 diabetes (T2D) remain poorly understood. It is commonly held that endothelial dysfunction and low-grade inflammation can explain, at least in part, why deteriorating glucose tolerance is associated with cardiovascular disease. However, there is no direct evidence for this contention. Methods and Results— In this population-based study (n=631), T2D was cross-sectionally associated with both endothelial dysfunction and low-grade inflammation, whereas impaired glucose metabolism (IGM) was associated only with low-grade inflammation. These findings were independent of other risk factors that accompany T2D or IGM. During a follow-up of 11.7 years (median; range 0.5 to 13.2 years), low-grade inflammation was associated with a greater risk of cardiovascular mortality (hazard ratio, 1.43 [95% CI, 1.17 to 1.77] per 1 SD difference). For endothelial dysfunction, the association with cardiovascular mortality was stronger in diabetic (hazard ratio, 1.87 [95% CI, 1.43 to 2.45]) than in nondiabetic individuals (hazard ratio, 1.23 [95% CI, 0.86 to 1.75]; P interaction=0.06). Finally, T2D-associated endothelial dysfunction and low-grade inflammation explained ≈43% of the increase in cardiovascular mortality risk conferred by T2D. Conclusions— These data emphasize the necessity of randomized controlled trials of strategies that aim to decrease cardiovascular disease risk by improving endothelial function and decreasing low-grade inflammation, especially for T2D patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000215951.36219.a4

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • T2DM is associated with low-grade inflammation, cardiovascular disease, nephropathy and alterations in secretion of various hormones including IL-6, IL-18, TNF-α, adiponectin, leptin, neuropeptides, ghrelin, and incretins GLP-1 and GIP.

    “Furthermore, T2DM is associated with low-grade inflammation,382, 383 cardiovascular disease,384, 385 nephropathy386, 387 and alterations in the secretion of various hormones, including IL-6, IL-18, tumor necrosis factor-α,388 adiponectin and leptin,389 neuropeptides,390 ghrelin391, 392 and the incretins GLP-1 and GIP.219, 220, 221, 222, 223”

    From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [383]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 50 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. Munro JM, Cotran RS. Biology of disease: the pathogenisis of atherosclero- sis: atherogenesis and inflammation. Lab Invest. 1988;58:249 -261.
  2. Stehouwer CDA, Lambert J, Donker AJM, van Hinsbergh VWM. Endothe- lial dysfunction and pathogenisis of diabetic angiopathy. Cardiovasc Res. 1997;34:55-68.
  3. Stehouwer CDA, Yudkin JS, Fioretto P, Nosadini R. How heterogeneous is microalbuminuria? The case for 'benign' and 'malignant' microalbuminuria. Nephrol Dial Transplant. 1998;13:2751-2754.
  4. World Health Organization. International Classification of Diseases, 9th ed, Vol. 1 and 2. Geneva, Switzerland: WHO; 1977.

Cited by

Sorted by citations

Authors
de Jager, J., Dekker, J. M., Kooy, A., Kostense, P. J., Nijpels, G., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A.
Affiliations
  • From the Department of Internal Medicine, Bethesda General Hospital, Hoogeveen, the Netherlands (J.d.J., A.K); the Institute for Research in Extramural Medicine (J.M.D., P.J.K., G.N., R.J.H., L.M.B., C.D.A.S.), VU University Medical Center, Amsterdam, The Netherlands; and the Department of Internal Medicine, University Hospital Maastricht, The Netherlands (C.D.A.S.).
  • Maastricht University Medical Centre (NL)
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2006-05
Volume
26
Issue
5
Pages
1086-1093
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2096259240
Cited by
163
References
50
Citations by year
2026: 5 · 2025: 8 · 2024: 5 · 2023: 7 · 2022: 8 · 2021: 8 · 2020: 7 · 2019: 5 · 2018: 3 · 2017: 7 · 2016: 9 · 2015: 13 · 2014: 8 · 2013: 8 · 2012: 10
FWCI
7.25
Type
journal article
Language
en
Open access
Locations
  • Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
  • PubMed (publishedVersion)
  • VU Research Portal (publishedVersion, other-oa)
  • Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
type 2 diabetes, endothelial dysfunction, low-grade inflammation, cardiovascular mortality, impaired glucose metabolism, cardiovascular risk, mediation analysis, endothelial function
MeSH terms
Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Endothelium, Vascular, Glucose, Glucose Tolerance Test, Humans, Inflammation, Male, Middle Aged, Prospective Studies, Cohort Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review